了解妇女对长效可逆避孕药的偏好在埃塞俄比亚的冈达尔:一个离散选择实验
Ousman Ambaw1, Amare Minyhun2, Tsegaw Amare Baykeda2,3
1Department of Health Systems and Policy, Institute of Public Health, University of Gondar, Gondar, Ethiopia. oustar111@gmail.com.
Health economics review
|October 21, 2025
概括
在埃塞俄比亚,长效可逆避孕药 (LARC) 的有限使用导致意外怀孕. 妇女支付LARC费用的意愿受提供者类型和大量出血等副作用的影响,这表明需要以用户为中心的服务.
科学领域:
- 生殖健康 生殖健康
- 避孕技术 避孕技术的使用
- 卫生经济学 卫生经济学
背景情况:
- 在埃塞俄比亚,长效可逆避孕药 (LARC) 的有限使用导致意外怀孕和产妇死亡率.
- 在埃塞俄比亚背景下,关于女性对LARC的偏好和支付意愿 (WTP) 的证据很少.
研究的目的:
- 为了检查妇女的声明偏好,支付意愿 (WTP),以及关于长效可逆避孕药 (LARC) 使用的权衡,在埃塞俄比亚的冈达尔.
主要方法:
- 进行了一项基于机构的跨部门研究,涉及344名避孕药使用者.
- 使用一个离散选择实验 (DCE),在24个选择任务中进行了8,256次观察.
- 混合逻辑模型被用来分析基于关键属性的偏好和WTP.
主要成果:
- 提供者类型显著影响了LARC的偏好,其中助产士是最受欢迎的.
- 妇女在LARC中表现出较高的WTP,副作用最小 (例如轻微体重增加,没有出血),有效性高.
- 严重的月经出血显著减少了WTP,突出显示它是LARC吸收的主要障碍.
结论:
- 妇女的LARC偏好是由提供者类型,副作用概况和成本决定的.
- 由助产士领导的LARC分娩和解决诸如大量月经出血等副作用对于增加吸收至关重要.
- 价格实惠,以用户为中心的避孕服务对于改善埃塞俄比亚LARC的使用是必不可少的.
更多相关视频
08:27Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
Published on: September 27, 2019
7.2K
12:14Exploring Life History Choices: Using Temperature and Substrate Type as Interacting Factors for Blowfly Larval and Female Preferences
Published on: November 17, 2023
1.8K
相关概念视频
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.3K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.3K
01:22Birth Control Methods
5.5K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
5.5K
01:19Modified-Release Drug Delivery Systems: Overview
231
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
231
01:26Oral Drug Delivery Systems: Continuous-Release Systems
293
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
293
01:11Oral Drug Delivery Systems: Delayed-Release Systems
201
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
201
01:21Intrauterine Drug Delivery Systems
161
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
161